These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10873965)

  • 21. [Observations on the increased serum levels of YKL-40 in patients with rheumatoid arthritis and osteoarthritis].
    Morgante M; Metelli MR; Morgante D
    Minerva Med; 2001 Jun; 92(3):151-3. PubMed ID: 11404723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial.
    Landewé RB; Houbiers JG; Van den Bosch F; in't Hout J; Verschueren PC; Meijerink JH; van den Hoogen FH; Masek BA; Bruyn GA; Wouters JM; Voskuyl AE; van Laar JM; Bijlsma JJ; van der Heijde DM; Breedveld FC; van de Putte LB; Miltenburg AM; de Keyser F
    Ann Rheum Dis; 2010 Sep; 69(9):1655-9. PubMed ID: 19778914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
    Wisłowska M; Jabłońska B
    Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity.
    Johansen JS; Stoltenberg M; Hansen M; Florescu A; Hørslev-Petersen K; Lorenzen I; Price PA
    Rheumatology (Oxford); 1999 Jul; 38(7):618-26. PubMed ID: 10461474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
    Ribbens C; Martin y Porras M; Franchimont N; Kaiser MJ; Jaspar JM; Damas P; Houssiau FA; Malaise MG
    Ann Rheum Dis; 2002 Feb; 61(2):161-6. PubMed ID: 11796404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication.
    Wisłowska M; Jabłońska B
    Rheumatol Int; 2005 Jun; 25(5):373-8. PubMed ID: 15739097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laborarory parameters.
    Matsumoto T; Tsurumoto T
    Clin Exp Rheumatol; 2001; 19(6):655-60. PubMed ID: 11791636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis.
    Skoumal M; Kolarz G; Haberhauer G; Woloszczuk W; Hawa G; Klingler A
    Rheumatol Int; 2005 Nov; 26(1):63-9. PubMed ID: 15889303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study.
    Conrozier T; Carlier MC; Mathieu P; Colson F; Debard AL; Richard S; Favret H; Bienvenu J; Vignon E
    Ann Rheum Dis; 2000 Oct; 59(10):828-31. PubMed ID: 11005786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation.
    Hu Y; Li H; Li WH; Meng HX; Fan YZ; Li WJ; Ji YT; Zhao H; Zhang L; Jin XM; Zhang FM
    Lupus; 2013 Dec; 22(14):1455-61. PubMed ID: 24122723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction.
    Johansen JS; Kirwan JR; Price PA; Sharif M
    Scand J Rheumatol; 2001; 30(5):297-304. PubMed ID: 11727845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients.
    Keenan RT; Swearingen CJ; Yazici Y
    Clin Exp Rheumatol; 2008; 26(5):814-9. PubMed ID: 19032813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmunity against YKL-39, a human cartilage derived protein, in patients with osteoarthritis.
    Tsuruha J; Masuko-Hongo K; Kato T; Sakata M; Nakamura H; Sekine T; Takigawa M; Nishioka K
    J Rheumatol; 2002 Jul; 29(7):1459-66. PubMed ID: 12136906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum matrix metalloproteinase-3 and fibrin degradation product levels correlate with clinical disease activity in rheumatoid arthritis.
    Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M
    Clin Exp Rheumatol; 1998; 16(5):533-40. PubMed ID: 9779299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis.
    van Bilsen JH; van Dongen H; Lard LR; van der Voort EI; Elferink DG; Bakker AM; Miltenburg AM; Huizinga TW; de Vries RR; Toes RE
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17180-5. PubMed ID: 15569925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased chromogranin A levels indicate sympathetic hyperactivity in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Capellino S; Lowin T; Angele P; Falk W; Grifka J; Straub RH
    J Rheumatol; 2008 Jan; 35(1):91-9. PubMed ID: 18061980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma and synovial fluid adipocytokines in patients with rheumatoid arthritis and osteoarthritis.
    Ibrahim SM; Hamdy MS; Amer N
    Egypt J Immunol; 2008; 15(1):159-70. PubMed ID: 20306680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family.
    Hakala BE; White C; Recklies AD
    J Biol Chem; 1993 Dec; 268(34):25803-10. PubMed ID: 8245017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between arthritis and human parvovirus B19 infection.
    Caliskan R; Masatlioglu S; Aslan M; Altun S; Saribas S; Ergin S; Uckan E; Koksal V; Oz V; Altas K; Fresko I; Kocazeybek B
    Rheumatol Int; 2005 Nov; 26(1):7-11. PubMed ID: 15322815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time.
    Becker-Merok A; Nikolaisen C; Nossent HC
    Lupus; 2006; 15(9):570-6. PubMed ID: 17080911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.